9 Meters Biopharma, Inc.
Treatment of cancer with larazotide derivatives in combination with immune checkpoint inhibitors
Last updated:
Abstract:
The present invention provides compositions and methods for treating a patient having cancer, as well as methods for potentiating an immune checkpoint inhibitor therapy. The methods comprise administering larazotide or a derivative thereof such as (d)-larazotide to a subject in need, including subjects undergoing checkpoint inhibitor therapy, and subjects scheduled to undergo immune checkpoint inhibitor therapy.
Status:
Grant
Type:
Utility
Filling date:
23 Apr 2021
Issue date:
22 Mar 2022